Alumis (ALMS) Shares Outstanding (2023 - 2026)
Alumis (ALMS) posted quarterly Shares Outstanding (Entity) of $85.1 million for Q4 2025, up 197.75% year-over-year from $28.6 million in Q4 2024, and down 18.46% quarter-over-quarter from $104.4 million in Q3 2025.
Analysis
Alumis (ALMS) Shares Outstanding (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Shares Outstanding (Entity) for 3 consecutive years, with $85.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 197.75% year-over-year to $85.1 million; the TTM figure through Dec 2025 stood at $85.1 million (up 197.75% YoY), while the FY2025 annual figure was $85.1 million, up 197.75% from the prior year.
- Shares Outstanding (Entity) declined to $85.1 million in Q4 2025 per ALMS's latest filing, from $104.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $104.4 million in Q3 2025 and bottomed at $2.6 million in Q2 2023.
- Historically, Shares Outstanding (Entity) has averaged $42.6 million across 3 years, with a median of $33.1 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) increased 3.56% — and 2025, when it jumped 2692.62%.
- Alumis' Shares Outstanding (Entity) stood at $23.8 million in 2023, then rose by 19.88% to $28.6 million in 2024, then jumped by 197.75% to $85.1 million in 2025.
- Business Quant data shows ALMS's Shares Outstanding (Entity) at $85.1 million in Q4 2025, $104.4 million in Q3 2025, and $76.6 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Alumis | 1.43 Bn | 924.11 Mn | - | 127.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 127.70 Mn |
| Dec 31, 2025 | 85.10 Mn |
| Sep 30, 2025 | 104.15 Mn |
| Jun 30, 2025 | 76.56 Mn |
| Mar 31, 2025 | 54.41 Mn |
| Dec 31, 2024 | 28.58 Mn |
| Sep 30, 2024 | 53.97 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 2.68 Mn |
| Dec 31, 2023 | 2.65 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 2.64 Mn |